Glaucoma, Primary Open Angle Clinical Trial
Official title:
Acute Changes in Optic Nerve Head (ONH) and Macular Blood Flow After Caffeine Consumption in Glaucoma Patients and Healthy Subjects: A Quantitative Optic Coherence Tomography Angiography (OCTA) Study
Caffeine is the most widely consumed drinking nutrient in the world. Caffeine effects various organs and the vascular system. It decreases ocular blood flow due to vasoconstriction.
Ingestion of caffeine in glaucoma patients and healthy subjects may decrease peripapillary and macular blood flow in the back of the eye. The primary objective of this study is to assess the acute changes in peripapillary and macular blood flow before and after an intake of oral caffeine (200 milligram tablet) in glaucoma patients and healthy subjects by using optical coherence tomography angiography (OCTA) scans. This novel imaging tool creates three-dimensional angiograms to assesses signal changes caused by flowing blood cells in a non-invasive angiogram scan. Blood flow is shown as vessel density measured in percentage. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02679482 -
Following Patients After Selective and Pascal Laser Trabeculoplasty for Treatment of Chronic Open-Angle Glaucoma
|
N/A | |
Recruiting |
NCT05999006 -
Safety and Feasibility of the ELIOS System in POAG Patients
|
N/A | |
Completed |
NCT05181046 -
Evaluation of Nanodropper-mediated Microdrops vs. Standard Drops of 0.5% Timolol Maleate in Glaucoma Patients
|
N/A | |
Completed |
NCT01999348 -
A Study of GANFORT® UD in Patients With Primary Open Angle Glaucoma (POAG) or Ocular Hypertension (OHT) in a Medical Setting
|
||
Completed |
NCT04149899 -
Safety and IOP-Lowering Effects of WB007
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT04007276 -
The Effect of Lumify™ on Ocular Redness, Intraocular Pressure, and Eyelid Position in Glaucoma Patients
|
Phase 4 | |
Completed |
NCT01814761 -
A Study of Bimatoprost 0.01% in the Clinical Setting
|
Phase 4 | |
Active, not recruiting |
NCT04899063 -
Excimer Laser Trabeculostomy Glaucoma Treatment Study
|
N/A | |
Completed |
NCT05474716 -
The Effect of Topical Brimonidine on the Ocular Hemodynamics in Patients of POAG Using OCTA
|
Phase 4 | |
Recruiting |
NCT03067415 -
Exploratory Trial to Evaluate the Efficacy and Safety of D565H Twice Daily Versus D565 Once Daily
|
Phase 2 | |
Not yet recruiting |
NCT06053307 -
Treating Psychosocial Distress in Glaucoma
|
N/A | |
Terminated |
NCT02858284 -
Evaluation of Safety and Efficacy of TUG (Therapeutic Ultrasound for Glaucoma) in the Treatment of Primary Open Angle Glaucoma or Ocular Hypertension
|
N/A | |
Completed |
NCT02796560 -
Generic Travoprost Versus Brand Name Travoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
|
Phase 4 | |
Recruiting |
NCT05370287 -
Adaptive Optics Retinal Imaging
|
N/A | |
Not yet recruiting |
NCT05673954 -
Glaucoma Assessment Via Reading Ability
|
||
Active, not recruiting |
NCT03318510 -
LSFG in Patients With Normal Tension Glaucoma Tension Glaucoma
|
N/A | |
Active, not recruiting |
NCT03151577 -
Longitudinal Study on Glaucoma Surgery Using XEN® Gel Stent
|
N/A | |
Completed |
NCT04465864 -
Investigate, Following Cataract Surgery With IOL in Conjunction With Intracanalicular Dexamethasone Insert
|
Phase 4 | |
Completed |
NCT01833741 -
A Study of LUMIGAN® RC in the Clinical Setting
|
Phase 4 | |
Completed |
NCT03800589 -
Assessment of Effectiveness Ex-Press Surgery Modification
|
N/A |